Employee Stock and Benefit Plans (Tables)

12 Months Ended

Oct. 01, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-Based Compensation Expense Recognized in the Consolidated Financial Statements

Stock-based compensation expense recognized in the consolidated financial statements (in millions):

Fiscal Year Ended	Oct 1, 2017		Oct 2, 2016		Sep 27, 2015
Options	$	44.3	$	42.7	$	37.8
RSUs	131.7		175.4		172.0
Total stock-based compensation expense recognized in the consolidated statements of earnings	$	176.0	$	218.1	$	209.8
Total related tax benefit	$	57.6	$	73.0	$	72.3
Total capitalized stock-based compensation included in net property, plant and equipment and inventories on the consolidated balance sheets	$	1.9	$	1.5	$	1.9

Employee Stock Options Granted During the Period, Valuation Assumptions

The fair value of stock option awards was estimated at the grant date with the following weighted average assumptions for fiscal years 2017, 2016 and 2015:

	Employee Stock Options Granted During the Period
Fiscal Year Ended	2017			2016			2015
Expected term (in years)	3.9			3.9			4.2
Expected stock price volatility	21.6		%	23.9		%	22.3		%
Risk-free interest rate	1.5		%	1.2		%	1.1		%
Expected dividend yield	1.8		%	1.3		%	1.6		%
Weighted average grant price	$	56.12		$	60.20		$	39.89
Estimated fair value per option granted	$	8.56		$	10.54		$	6.58

Stock Option Transactions

Stock option transactions for the year ended October 1, 2017(in millions, except per share and contractual life amounts):

	Shares Subject to Options		Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Outstanding, October 2, 2016	31.3		$	30.59	5.8	$	771
Granted	7.1		56.12
Exercised	(5.3	)	23.16
Expired/forfeited	(1.7	)	51.13
Outstanding, October 1, 2017	31.4		36.51		5.8	589
Exercisable, October 1, 2017	19.7		26.42		4.2	552
Vested and expected to vest, October 1, 2017	30.0		35.60		5.6	587

RSU Transactions

RSU transactions for the year ended October 1, 2017(in millions, except per share and contractual life amounts):

	Number of Shares		Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Nonvested, October 2, 2016	8.3		$	46.15	0.9	$	448
Granted	5.1		54.30
Vested	(4.3	)	42.09
Forfeited/canceled	(1.5	)	51.05
Nonvested, October 1, 2017	7.6		52.06		0.9	410